Pneumococcal 13-valent Conjugate Vaccine
Suspension for intramuscular injection. Initial US Approval: 2010
Facts about Pneumococcal 13-valent Conjugate Vaccine
Approval Date: 2010
Proprietary Name: On Request
Active Ingredient(s): Pneumococcal 13-valent Conjugate Vaccine
Dosage Forms And Strengths: 0.5 mL suspension for intramuscular injection, supplied in a single-dose prefilled syringe.
Disease: Pneumococcal disease
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)
Access the best support services globally
If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Pneumococcal 13-valent Conjugate Vaccine” based on the information you provide.
Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.